NRX-1532

• CAT Number: I043868
• Molecular Formula: C16H11F3N4O2
• Molecular Weight: 348.28
• Purity: ≥95%
• Synonyms: 2-oxo-N-[3-(1H-pyrazol-5-yl)phenyl]-6-(trifluoromethyl)-1H-pyridine-3-carboxamide
• InChI: InChI=1S/C16H11F3N4O2/c17-16(18,19)13-5-4-11(15(25)22-13)14(24)21-10-3-1-2-9(8-10)12-6-7-20-23-12/h1-8H,(H,20,23)(H,21,24)(H,22,25)
• InChIKey: KRFAUNDDLPKBNF-UHFFFAOYSA-N
• SMILES: C1=CC(=CC(=C1)NC(=O)C2=CC=C(NC2=O)C(F)(F)F)C3=CC=NN3

NRX-1532（Cat No.:I043868）is a selective small molecule designed to target and inhibit the activity of specific pathways involved in neuroinflammation and neurodegeneration. It is being investigated for its potential therapeutic effects in treating neurological disorders such as Alzheimer’s disease and Parkinson’s disease. By modulating key receptors and signaling pathways, NRX-1532 aims to reduce neuroinflammatory responses and promote neuroprotection. It is currently being studied in preclinical research to evaluate its efficacy in alleviating symptoms associated with neurodegenerative diseases, offering a promising approach to novel treatments in neurology.